A Short Pulse of IL-4 Delivered by DCs Electroporated With Modified mRNA Can Both Prevent and Treat Autoimmune Diabetes in NOD Mice

This publication has 31 references indexed in Scilit:

• Immunologic activity and safety of autologous HIV RNA-electroporated dendritic cells in HIV-1 infected patients receiving antiretroviral therapy
  Clinical Immunology, 2010
• Lymphoid tissue–specific homing of bone marrow–derived dendritic cells
  Blood, 2009
• Host natural killer T cells induce an interleukin-4–dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease
  Blood, 2009
• In situ Expression of Tumor Antigens by Messenger RNA–Electroporated Dendritic Cells in Lymph Nodes of Melanoma Patients
  Cancer Research, 2009
• Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial
  Cytotherapy, 2009
• Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice
  Clinical Immunology, 2008
• Cytokine Maturation Followed by CD40L mRNA Electroporation Results in a Clinically Relevant Dendritic Cell Product Capable of Inducing a Potent Proinflammatory CTL Response
  Journal of Immunotherapy, 2008
• Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyond
  Pediatric Diabetes, 2008
• Prevention of type 1 diabetes: the time has come
  Nature Clinical Practice Endocrinology & Metabolism, 2008
• Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells.
  2000